Article info
Rheumatoid arthritis
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
- Correspondence to Maxime MA Verhoeven, Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht 3508 GA, The Netherlands; m.m.a.verhoeven-15{at}umcutrecht.nl
Citation
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
Publication history
- Received February 28, 2019
- Revised May 24, 2019
- Accepted May 25, 2019
- First published June 13, 2019.
Online issue publication
September 12, 2019
Article Versions
- Previous version (13 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.